Literature DB >> 8987954

Prospective assessment of pregnancy outcomes after first-trimester exposure to fluconazole.

P Mastroiacovo1, T Mazzone, L D Botto, M A Serafini, A Finardi, L Caramelli, D Fusco.   

Abstract

OBJECTIVE: Our purpose was to study prospectively the pregnancy outcome after first-trimester exposure to fluconazole, an effective antifungal agent teratogenic in animals. STUDY
DESIGN: We conducted a prospective cohort study of women who contacted three Italian teratogen information services. We compared the pregnancy outcomes of 226 women exposed to fluconazole with that of 452 women exposed to nonteratogenic agents, with use of logistic regression to control for potential confounders.
RESULTS: Among the 226 pregnancies exposed to fluconazole there were 22 miscarriages, 1 stillbirth, and 7 infants with congenital anomalies. The prevalence of these outcomes and of neonatal growth parameters and the rate of neonatal complications were similar to those in the reference group. Women in the fluconazole group had a fivefold increased occurrence of induced abortions.
CONCLUSIONS: First-trimester exposure to fluconazole does not appear to increase the prevalence of miscarriages, congenital anomalies, and low birth weight.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8987954     DOI: 10.1016/s0002-9378(96)70119-9

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  16 in total

Review 1.  Medical genetics: 1. Clinical teratology in the age of genomics.

Authors:  Janine E Polifka; J M Friedman
Journal:  CMAJ       Date:  2002-08-06       Impact factor: 8.262

2.  Evidence for digenic inheritance in some cases of Antley-Bixler syndrome?

Authors:  W Reardon; A Smith; J W Honour; P Hindmarsh; D Das; G Rumsby; I Nelson; S Malcolm; L Adès; D Sillence; D Kumar; C DeLozier-Blanchet; S McKee; T Kelly; W L McKeehan; M Baraitser; R M Winter
Journal:  J Med Genet       Date:  2000-01       Impact factor: 6.318

3.  Candida Vulvovaginitis in Pregnancy.

Authors:  Jinping Xu; Jack D Sobel
Journal:  Curr Infect Dis Rep       Date:  2004-12       Impact factor: 3.725

4.  Vulvovaginal Candidosis (excluding chronic mucocutaneous candidosis). Guideline of the German Society of Gynecology and Obstetrics (AWMF Registry No. 015/072, S2k Level, December 2013).

Authors:  W Mendling; K Friese; I Mylonas; E-R Weissenbacher; J Brasch; M Schaller; P Mayser; I Effendy; G Ginter-Hanselmayer; H Hof; O Cornely; M Ruhnke
Journal:  Geburtshilfe Frauenheilkd       Date:  2015-04       Impact factor: 2.915

5.  PURLs: Yeast infection in pregnancy? Think twice about fluconazole.

Authors:  Amir Barzin; Anne Mounsey
Journal:  J Fam Pract       Date:  2016-09       Impact factor: 0.493

6.  Cryptococcosis in pregnancy and the postpartum period: Case series and systematic review with recommendations for management.

Authors:  Katelyn A Pastick; Elizabeth Nalintya; Lillian Tugume; Kenneth Ssebambulidde; Nicole Stephens; Emily E Evans; Jane Frances Ndyetukira; Edwin Nuwagira; Caleb Skipper; Conrad Muzoora; David B Meya; Joshua Rhein; David R Boulware; Radha Rajasingham
Journal:  Med Mycol       Date:  2020-04-01       Impact factor: 4.076

Review 7.  Use of antifungal drugs in pregnancy: a focus on safety.

Authors:  J D Sobel
Journal:  Drug Saf       Date:  2000-07       Impact factor: 5.606

8.  Vulvovaginal candidiasis in pregnancy.

Authors:  T J Aguin; J D Sobel
Journal:  Curr Infect Dis Rep       Date:  2015-06       Impact factor: 3.725

9.  Evaluation and treatment of the human immunodeficiency virus-1-exposed infant.

Authors: 
Journal:  Paediatr Child Health       Date:  2004-07       Impact factor: 2.253

Review 10.  Pharmacologic advances in canine and feline reproduction.

Authors:  Valerie J Wiebe; James P Howard
Journal:  Top Companion Anim Med       Date:  2009-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.